Table 3 Association of PLTP expression levels with clinicopathological characteristics in patients with DLBCL
Characteristic | Total no | Low expression, No. (%) | High expression, No. (%) | Pearson χ2 | p-value |
|---|---|---|---|---|---|
Gender |  |  |  |  < 0.0001 | 0.987 |
 Male | 55 | 36 (65.5) | 19 (34.5) |  |  |
 Female | 49 | 32 (65.3) | 17 (34.7) | ||
Age (year) | Â | Â | Â | 0.025 | 0.874 |
 ≤ 60 | 56 | 37 (66.1) | 19 (33.9) |  |  |
 > 60 | 48 | 31 (64.6) | 17 (35.4) | ||
B symptoms | Â | Â | Â | 1.18 | 0.277 |
 No | 84 | 57 (67.9) | 27 (32.1) |  |  |
 Yes | 20 | 11 (55.0) | 9 (45.0) | ||
Ann Arbor stage | Â | Â | Â | 4.007 | 0.045 * |
 I or II | 76 | 54 (71.1) | 22 (28.9) |  |  |
 III or IV | 28 | 14 (50.0) | 14 (50.0) | ||
Hb level (g/L) | Â | Â | Â | 2.579 | 0.108 |
 ≥ 120 | 63 | 45 (71.4) | 18 (28.6) |  |  |
 < 120 | 41 | 23 (56.1) | 18 (43.9) | ||
LDH level (g/L) | Â | Â | Â | 0.465 | 0.495 |
 Normal | 51 | 35 (68.6) | 16 (31.4) |  |  |
 Elevated | 53 | 33 (62.3) | 20 (37.7) | ||
IPI score | Â | Â | Â | 0.184 | 0.668 |
 0–2 | 55 | 37 (67.3) | 18 (32.7) |  |  |
 3–5 | 49 | 31 (63.3) | 18 (36.7) |  |  |